Abstract
Adenosine 5′-diphosphate (ADP) stimulates platelets to change shape, to develop an adhesiveness that is associated with the exposure of receptors for fibrinogen and, in the presence of sufficient calcium, to aggregate and release the contents of storage granules. These effects of ADP are competitively inhibited by the related nucleotides adenosine 5′-triphosphate (ATP) and adenosine 5′-monophosphate (AMP) which interact with the ADP receptor.1,2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G. V. R. Born, and M. J. Cross, The aggregation of blood platelets, J. Physiol. 168:178 (1963).
D. E. Macfariane, and D. C. B. Mills, The effects of ATP on platelets: Evidence against the central role of released ADP in primary aggregation, Blood 46:309 (1975).
D. C. B. Mills, and J. B. Smith, The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3f,5f-cyclic monophosphate in platelets, Biochem. J. 121:185 (1971).
R. J. Haslam, and G. M. Rosson, Effects of adenosine on levels of adenosine cyclic 3′,5′-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation, Mol. Pharmacol. 11:528 (1975).
R. J. Haslam, M.M.L. Davidson, and J.V. Desjardins, Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets, Biochem. J. 176:83 (1978).
R. J. Haslam, S. E. Salama, J. E. B. Fox, J. A. Lynham, and M. M. L. Davidson, Roles of cyclic nucleotides and of protein phosphorylation in the regulation of platelet function, in: “Platelets: Cellular Response Mechanisms and their Biological Significanee,” A. Rotman, F.A. Meyer, C. Gitler, and A. Silberberg, eds., Wiley, Chichester (1980).
D. E. Knight, and M. C. Scrutton, Cyclic nucleotides control a system which regulates Ca2+ sensitivity of platelet secretion, Nature, 309:66 (1984).
E. W. Salzman, Cyclic AMP and platelet function, N. Eng. J. Med. 286:358 (1972).
E. W. Salzman, D. E. MacIntyre, M. L. Steer, and J. L. Gordon, Effect on platelet activity of inhibition of adenylate cyclase, Thrombos. Res. 13:1089 (1978).
D. N. Harris, M. M. Asaad, M. B. Phillips, H. J. Goldenberg, and M. J. Antonaccio, Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives, J. Cyclic Nuc. Res. 5: 125 (1979).
R. J. Haslam, and N. J. Cusack, Blood platelet receptors for ADP and for adenosine, in: “Purinergic Receptors: Receptors and Recognition Series B Volume 12,” G. Burnstock, ed., Chapman and Hall, London (1981).
A. Gaarder, J. Jonsen, S. Laland, A. Hellem, and P. A. Owren, Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets, Nature 192:531 (1961).
N. J. Cusack, and S. M. O. Hourani, Partial agonist behaviour of adenosine 5′-O- (2-thiodiphosphate), Br. J. Pharmac. 73:405 (1981).
N. J. Cusack, and S. M. O. Hourani, Effects of Rp and Sp diastereoisomers of adenosine 5′-O-(1-thiodiphosphate) on human platelets, Br. J. Pharmac. 73:409 (1981).
N. J. Cusack, and S. M. O. Hourani, unpublished.
G. Gough, M. H. Maguire, and F. Penglis, Analogues of adenosine 5′-diphosphate — new platelet aggregators, Mol. Pharmacol. 8:170 (1972),
A. Gaarder, and S. Laland, Hypothesis for the aggregation of platelets by nucleotides, Nature 202:909 (1964)
B. H. Ragatz, P. G. Iatridis, S. G. Iatridis, S. G. Markidou, M. F. Asterita, and J. Gadarowski, Interactions of the ADP analogs, 2′-O-methyl ADP and adenine 9-β-D-arabinofuranoside 5′-diphosphate and catecholamines with human platelets, Thrombos. Haemostas. 38:209 (1977).
P. H. Pearce, J. M. Wright, C. M. Egan, and M. C. Scutton, Interaction of human blood platelets with the 2′,3′-dialdehyde and 2′,3′-dialcohol derivatives of adenosine 5′-diphosphate and adenosine 5′-triphosphate, Eur. J. Biochem. 88:543 (1978).
J. V. Stone, R. K. Singh, H. Horak, and P. G. Barton, Sulfhydryl analogues of adenosine diphosphate: chemical synthesis and activity as platelet-aggregating agents, Can. J. Biochem. 54:529 (1976).
N. J. Cusack, and G. V. R. Born, Effects of photolysable 2-azido analogues of adenosine, AMP and ADP on human platelets, Proc. R. Soc. Lond. B 197:515 (1977).
F. A. Robey, G. A. Jamieson, and J. B. Hunt, Synthesis and use of a new spin-labeled analogue of ADP with platelet-aggregating activity, J. Biol. Chem. 254:1114 (1979).
N. J. Cusack, M. E. Hickman, and G. V. R. Born, Effects of D-and L- enantiomers of adenosine, AMP and ADP and their 2-chloro- and 2-azido- analogues on human platelets, Proc. R. Soc. Lond. B 206:139 (1979).
N. J. Cusack, and S. M. O. Hourani, Adenosine 5′-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors, Br. J. Pharmac. 76:221 (1982).
N. J. Cusack, and S. M. O. Hourani, Competitive inhibition by adenosine 5′-triphosphate of the actions on human platelets of 2-chloroadenosine 5′-diphosphate, 2-azidoadenosine 5′-diphosphate and 2-methylthioadenosine 5′-diphosphate, Br. J. Pharmac. 77:329 (1982).
D. E. Macfariane, D. C. B. Mills, and P. C. Srivastava, Binding of 2-azidoadenosine [β-32] diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase, Biochemistry 21:544 (1982).
D. E. Macfarlane, P. C. Srivastava, and D. C. B. Mills, 2-Methylthioadenosine [β-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets, J. Clin. Invest. 71:420 (1983).
N. J. Cusack, and S. M. O. Hourani, Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5′-O-(1-thiodiphosphate) and adenosine 5′-O-(2-thiodiphosphate), Br. J. Pharmac. 75:257 (1982).
R. W. Colman, W. R. Figures, R. F. Colman, T. A. Morinelli, S. Niewiarowski, and D. C. B. Mills, Identification of two distinct adenosine diphosphate receptors in human platelets, Trans. Assoc. Am. Physic. 93:305 (1980).
M. H. Maguire, Adenine nucleotides as tools in platelet studies, Proc. West. Pharmacol. Soc. 24:381 (1981).
R. W. Colman, and W. R. Figures, Characteristics of an ADP receptor mediating platelet activation, Mol. Cell. Biochem. 59:101 (1984).
G. R. Gough, D. M. Nobbs, J. C. Middleton, F. Penglis-Caredes, and M. H. Maguire, New inhibitors of platelet aggregation. 5′-Phosphate, 5′-phosphorothioate and 5′-O-sulfamoyl derivatives of 2-substituted adenosine analogues, J. Med. Chem. 21:520 (1978).
N. J. Cusack, and S. M. O. Hourani, Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5′-monophosphate and adenosine 5′-triphosphate of human platelet aggregation induced by adenosine 5′-diphosphate, Br. J. Pharmac. 75:397 (1982).
J. J. Czarnecki, M. S. Abbott, and B. R. Selman, Photoaffinity labeling with 2-azidoadenosine diphosphate of a tight nucleotide binding site on chloroplast coupling factor 1, Proc. Natl. Acad. Sci. USA 79:7744 (1982).
G. Burnstock, and C. M. Brown, An introduction to purinergic receptors, in: “Purinergic Receptors: Receptors and Recognition Series B. Volume 12,” G. Burnstock, ed., Chapman and Hall, London (1981).
M. H. Maguire, and D. G. Satchell, Purinergic receptors in visceral smooth muscle, in: “Purinergic Receptors: Receptors and Recognition Series B Volume 12,” G. Burnstock, ed., Chapman and Hall, London (1981).
P. Lukacsko, and R. D. Krell, Response of the guinea-pig urinary bladder to purine and pyrimidine nucleotides, Eur. J. Pharmac. 80:401 (1982).
G. Burnstock, N. J. Cusack, J. M. Hills, I. MacKenzie, and P. Meghji, Studies on the stereoselectivity of the P2-purinoceptor, Br. J. Pharmac. 79:907 (1983).
N. J. Cusack, and S. M. O. Hourani, Some pharmacological and biochemical interactions of the enantiomers of adenylyl 5′- (β,γ-methylene)-diphosphonate with the guinea-pig urinary bladder, Br. J. Pharmac. 82:155 (1984).
S. M. O. Hourani, Desensitisation of the guinea-pig urinary bladder by the enantiomers of adenylyl 5′-(β,γ-methylene)-diphosphonate and by substance P, Br. J. Pharmac. 82:161 (1984).
G. Burnstock, N. J. Cusack, and L. A. Meldrum, Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea-pig taenia coli and urinary bladder, Br. J. Pharmac. 82:369 (1984).
N. J. Cusack, and M. Planker, Relaxation of isolated taenia coli of guinea-pig by enantiomers of 2-azido analogues of adenosine and adenine nucleotides, Br. J. Pharmac. 67:153 (1979).
J. D. Pearson, N. J. Cusack, and W. Martin, Discrimination between ecto-ATPase and P2 purinoceptors on porcine aortic endothelium, in: IUPHAR 9th International Congress of Pharmacology, 1913P (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Cusack, N.J., Hourani, S.M.O., Welford, L.A. (1985). Characterisation of ADP Receptors. In: Westwick, J., Scully, M.F., MacIntyre, D.E., Kakkar, V.V. (eds) Mechanisms of Stimulus—Response Coupling in Platelets. Advances in Experimental Medicine and Biology, vol 192. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9442-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9442-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9444-4
Online ISBN: 978-1-4615-9442-0
eBook Packages: Springer Book Archive